| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,2 M € | -12.6% | 6,0 M € | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2,0 M € | -15.0% | 2,3 M € | +35.2% | 1,7 M € | ||||||||||||||||
| Gross margin | 2,4 M € | +33.4% | 1,8 M € | -35.2% | 2,8 M € | +3.5% | 2,7 M € | -74.8% | 10,8 M € | +266.4% | 3,0 M € | +20.9% | 2,4 M € | -8.9% | 2,7 M € | +1.2% | 2,7 M € | +63.0% | 1,6 M € | -5.7% | 1,7 M € | -6.5% | 1,8 M € | +9.8% | 1,7 M € | +25.7% | 1,3 M € | +1.9% | 1,3 M € | -26.7% | 1,8 M € | +65.1% | 1,1 M € | -13.1% | 1,2 M € | +35.0% | 923,9 k € | |
| EBITDA | 321,8 k € | +624.3% | -61,4 k € | -107.7% | 800,4 k € | -14.7% | 938,3 k € | -89.6% | 9,0 M € | +642.2% | 1,2 M € | +62.8% | 744,8 k € | -16.2% | 889,2 k € | -18.4% | 1,1 M € | +244.1% | 316,8 k € | -36.9% | 502,1 k € | -25.8% | 676,4 k € | +51.6% | 446,1 k € | +619.8% | 62,0 k € | -63.6% | 170,2 k € | -80.9% | 890,6 k € | +383.2% | 184,3 k € | -0.1% | 184,6 k € | -37.8% | 296,9 k € | |
| Operating profit | -430,0 k € | +50.5% | -867,9 k € | -752.0% | -101,9 k € | +72.2% | -366,6 k € | -104.8% | 7,6 M € | +12918.4% | 58,3 k € | +108.3% | -699,2 k € | +16.0% | -832,4 k € | -17.7% | -707,5 k € | -75.2% | -403,8 k € | -8754.3% | -4,6 k € | -101.3% | 359,4 k € | +43.7% | 250,1 k € | +877.9% | -32,1 k € | -143.8% | 73,3 k € | -91.0% | 819,0 k € | +643.7% | 110,1 k € | +37.1% | 80,3 k € | -63.5% | 219,8 k € | |
| Profit/loss | -471,3 k € | +44.7% | -852,8 k € | -3037.6% | -27,2 k € | +93.1% | -394,0 k € | -105.7% | 6,9 M € | +3281.1% | 203,2 k € | +140.2% | -505,1 k € | -28.0% | -394,7 k € | -136.5% | -166,9 k € | -253.2% | 109,0 k € | -69.8% | 360,6 k € | -20.9% | 455,9 k € | +74.3% | 261,5 k € | +420.4% | -81,6 k € | -232.7% | 61,5 k € | -89.2% | 572,0 k € | +730.2% | 68,9 k € | +19.9% | 57,5 k € | -60.5% | 145,6 k € | |
| Equity | 5,4 M € | -8.3% | 5,9 M € | -15.0% | 7,0 M € | -0.3% | 7,0 M € | -11.6% | 7,9 M € | +1517.6% | 488,5 k € | -23.5% | 638,4 k € | -57.6% | 1,5 M € | -35.3% | 2,3 M € | -23.7% | 3,0 M € | +20.2% | 2,5 M € | +24.6% | 2,0 M € | +28.8% | 1,6 M € | +55.1% | 1,0 M € | -7.4% | 1,1 M € | +5.9% | 1,0 M € | +122.4% | 467,2 k € | +11.0% | 421,0 k € | +15.8% | 363,5 k € | |
| Total assets | 6,9 M € | -9.4% | 7,6 M € | -12.3% | 8,7 M € | -6.0% | 9,2 M € | -22.9% | 12,0 M € | +229.4% | 3,6 M € | -11.8% | 4,1 M € | +9.5% | 3,8 M € | +0.2% | 3,8 M € | -27.0% | 5,2 M € | +11.4% | 4,6 M € | +25.7% | 3,7 M € | +5.3% | 3,5 M € | +52.8% | 2,3 M € | -4.9% | 2,4 M € | +13.4% | 2,1 M € | +75.5% | 1,2 M € | +17.7% | 1,0 M € | -8.5% | 1,1 M € | |
| Cash | 1,6 M € | -40.9% | 2,7 M € | -26.3% | 3,7 M € | -0.7% | 3,7 M € | -48.5% | 7,3 M € | +500.5% | 1,2 M € | -9.3% | 1,3 M € | +48.1% | 899,8 k € | +6.3% | 846,6 k € | -20.7% | 1,1 M € | -26.4% | 1,5 M € | +56.7% | 925,2 k € | +9.4% | 845,7 k € | +194.0% | 287,6 k € | +769.6% | 33,1 k € | +6.4% | 31,1 k € | -71.2% | 108,0 k € | +1048.1% | 9,4 k € | -95.7% | 219,8 k € | |
| Debts | 1,5 M € | -5.2% | 1,6 M € | +0.6% | 1,5 M € | -31.4% | 2,2 M € | -44.4% | 4,0 M € | +29.2% | 3,1 M € | -5.3% | 3,3 M € | +46.7% | 2,3 M € | +57.9% | 1,4 M € | -31.8% | 2,1 M € | +0.5% | 2,1 M € | +27.5% | 1,6 M € | -14.6% | 1,9 M € | +187.3% | 664,8 k € | -38.6% | 1,1 M € | +0.6% | 1,1 M € | +47.8% | 727,6 k € | +28.2% | 567,5 k € | -5.4% | 599,9 k € | |
| Staff | 31,5 | 26,6 | 29,8 | 30,2 | 31,5 | 28,3 | 29,3 | 30,6 | 28,9 | 25,6 | 23,1 | 22,9 | 22,6 | 23,1 | 21,4 | 20,8 | 17,8 | 18,4 | 16,2 | |||||||||||||||||||
Private limited company · Gembloux · incorporated on 16/10/1996 · 31,5 ETP
Private limited company loss-making in the latest fiscal year. Cash position declining (-40.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CORIS BIOCONCEPT is a Private limited company incorporated in 1996. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gembloux. It employs on average 31,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette